Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
4.580
+0.140 (3.15%)
Apr 26, 2024, 10:36 AM EDT - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $163.49 million as of April 26, 2024. Its market cap has decreased by -68.21% in one year.
Market Cap
163.49M
Enterprise Value
72.94M
1-Year Change
-68.21%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $183.30M to $163.49M, a decrease of -10.81%. That is a compound annual growth rate of -3.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 158.90M | -0.87% |
Apr 24, 2024 | 160.30M | -0.87% |
Apr 23, 2024 | 161.70M | 0.43% |
Apr 22, 2024 | 161.00M | -3.01% |
Apr 19, 2024 | 166.00M | -1.48% |
Apr 18, 2024 | 168.50M | 1.94% |
Apr 17, 2024 | 165.30M | -0.84% |
Apr 16, 2024 | 166.70M | -3.75% |
Apr 15, 2024 | 173.20M | -1.03% |
Apr 12, 2024 | 175.00M | -3.15% |
Apr 11, 2024 | 180.70M | 3.26% |
Apr 10, 2024 | 175.00M | - |
Apr 9, 2024 | 175.00M | -0.79% |
Apr 8, 2024 | 176.40M | 0.80% |
Apr 5, 2024 | 175.00M | -1.57% |
Apr 4, 2024 | 177.80M | 1.43% |
Apr 3, 2024 | 175.30M | -2.77% |
Apr 2, 2024 | 180.30M | 1.81% |
Apr 1, 2024 | 177.10M | -6.05% |
Mar 28, 2024 | 188.50M | -0.68% |
Mar 27, 2024 | 189.80M | 0.96% |
Mar 26, 2024 | 188.00M | 5.20% |
Mar 25, 2024 | 178.70M | -4.95% |
Mar 22, 2024 | 188.00M | -0.95% |
Mar 21, 2024 | 189.80M | -0.68% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Inogen | 166.01M |
Quipt Home Medical | 163.47M |
Greenwich LifeSciences | 162.53M |
ProQR Therapeutics | 162.44M |
scPharmaceuticals | 162.24M |
Harvard Bioscience | 160.14M |
Gossamer Bio | 159.78M |
Capricor Therapeutics | 158.78M |